Virus-mimicking TB may offer therapeutic opportunities A study shows that TB bacteria release a section of DNA, a virus-mimicking molecule called c-di-AMP, and its behaviour offers drug and vaccine possibilities.…
US FDA approves antibiotic combination with new beta-lactamase inhibitor The US Food and Drug Administration has approved a new intravenous antibacterial product, Avycaz, which contains ceftazidime and a new beta-lactamase inhibitor, avibactam.…
Genetic risk for coronary events linked to statin response Patients with high and intermediate genetic risk for coronary heart disease benefit more from statin therapy than patients at low genetic risk, researchers have shown.…
Researchers look to spider venom for new analgesics Scientists have identified a potent modulator of voltage-gated sodium (NaV) channels from spider venom, which could hold promise as a new analgesic.…
Contain eating to a 12-hour window to contain weightPamela Mason describes research that suggests eating in a confined window of time may help to reduce weight gain.…
Could a probiotic pill cure diabetes?Recent news stories have suggested that a new probiotic pill could cure both type 1 and type 2 diabetes. However, much more research is required before these claims can be substantiated, writes Pamela Mason.…
Rheumatologists want to see system in place to track efficacy and safety of biosimilar products The British Society of Rheumatology (BSR) wants patients to register with its evidence database to track the efficacy and long-term safety of new biosimilar products.…
Low molecular weight heparins for treating venous thromboembolism How to start patients on these common injected anticoagulants and optimise treatment.…
Young people contract flu more frequently than adults aged over 30 Young people seem to contract influenza every other year on average, while adults over 30 seem to contract flu twice a decade, say researchers.…
Paracetamol use linked with cardiovascular risk and other adverse events Researchers have discovered a consistent dose-response relationship between paracetamol use and risk of mortality or cardiovascular, gastrointestinal or renal adverse events.…